Hospira joins GPhA

LAKE FOREST, Ill. — Generic drug maker Hospira has joined the country's largest lobby for the generic drug industry, the company said.



Hospira, which specializes in generic injectables and infusion technology, announced that it had joined the Generic Pharmaceutical Association. In addition to generic pharmaceuticals, the company also makes biosimilars for the European market.



"We are pleased to welcome Hospira to GPhA, and we look forward to their joining in the association's mission to improve the lives of consumers by providing timely access to affordable pharmaceuticals," GPhA president and CEO Ralph Neas said.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.